170 related articles for article (PubMed ID: 23566475)
1. Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma.
Butt AS; Hamid S; Wadalawala AA; Ghufran M; Javed AA; Farooq O; Ahmed B; Ul Haq T; Jafri W
BMC Res Notes; 2013 Apr; 6():137. PubMed ID: 23566475
[TBL] [Abstract][Full Text] [Related]
2. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
4. A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patients.
Ul Abideen Z; Siddique S; Nasrullah I; Khan JS; Rehman S; Tong Y; Qamar R; Butt AM
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1103-1109. PubMed ID: 30829691
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
Aljumah AA; Kuriry H; Faisal N; Alghamdi H
Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
[TBL] [Abstract][Full Text] [Related]
6. Why is hepatocellular carcinoma less attributable to viral hepatitis in Yemen?
Saeed NM; Bawazir AA; Al-Zuraiqi M; Al-Negri F; Yunus F
Asian Pac J Cancer Prev; 2012; 13(8):3663-7. PubMed ID: 23098451
[TBL] [Abstract][Full Text] [Related]
7. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome.
Chang PE; Ong WC; Lui HF; Tan CK
J Gastroenterol; 2008; 43(11):881-8. PubMed ID: 19012042
[TBL] [Abstract][Full Text] [Related]
8. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
Schauer C; Mules T; Rijnsoever MV; Gane E
N Z Med J; 2020 May; 133(1515):25-34. PubMed ID: 32438374
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
Makarova M; Krettek A; Valkov MY; Grjibovski AM
Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia.
Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):541-546. PubMed ID: 32660841
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in Senegal: epidemiological, clinical and etiological aspects about 229 cases at
Diallo I; Ndiaye B; Touré M; Sow A; Mbengue A; Diawara PS; Gning SB; Mbaye PS; Fall F; Mbengue M
Pan Afr Med J; 2021; 38():99. PubMed ID: 33889265
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of liver cancer at Khmer-soviet Friendship Hospital in Phnom Penh, Cambodia.
Narin P; Hamajima N; Kouy S; Hirosawa T; Eav S
Asian Pac J Cancer Prev; 2015; 16(1):35-9. PubMed ID: 25640378
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
[TBL] [Abstract][Full Text] [Related]
16. The clinical and pathological features of hepatocellular carcinoma in Nnewi, Nigeria.
Okonkwo UC; Nwosu MN; Ukah C; Okpala OC; Ahaneku JI
Niger J Med; 2011; 20(3):366-71. PubMed ID: 21970220
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927
[TBL] [Abstract][Full Text] [Related]
18. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of hepatocellular carcinoma in Japan.
Okita K
Intern Med; 2006; 45(5):229-33. PubMed ID: 16595985
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus-related hepatocellular carcinoma presenting at an advanced stage: is it preventable?
Mules T; Gane E; Lithgow O; Bartlett A; McCall J
N Z Med J; 2018 Nov; 131(1486):27-35. PubMed ID: 30496164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
